We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $2.58M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$731K | |
| 2 | +$229K | |
| 3 | +$216K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$155K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$14.9K |
Top Sellers
| 1 | -$978K | |
| 2 | -$693K | |
| 3 | -$6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.33K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$854 |